Geospiza has been around the block a time or two in the bioinformatics business, and after 14 years in the game, it has come to the end of the road.
The Seattle-based company, which makes software for scientists who analyze data from genetic experiments, said last week it has agreed to be acquired by Waltham-based PerkinElmer, the giant maker of tools for life scientists. PerkinElmer, which said it generated $448 million in first-quarter revenue, did not disclose how much it paid to obtain Geospiza. PerkinElmer CEO Rob Friel did say in a conference call that the acquisition will have “minimal impact’’ on his company’s near-term finances, and that it represents a strong growth opportunity.
